The islet's glucose sensor: beta cells are the endocrine cells of the pancreatic islets that make and release insulin — the only hormone that lowers blood glucose — and the sole site of insulin synthesis in mammals.
Islets of Langerhans, interspersed with alpha cells
Key Markers
Insulin expression; GLUT1 and GLUT3; glucokinase
Main Secretions
Insulin, C-peptide (equimolar), amylin
Associated Conditions
Type 1 and type 2 diabetes mellitus
Identity & Markers
Beta cells constitute roughly 50 to 70 percent of the cells in human islets.
Insulin is encoded as a 110-amino-acid precursor and secreted as a 51-amino-acid protein; proinsulin, folded by three disulfide bonds, is cleaved to insulin plus C-peptide.
C-peptide is secreted equimolar with insulin and may help prevent diabetic neuropathy and vascular deterioration.
Structure & Location
Human islets display alpha and beta cells in close relationship throughout the cluster — no beta-cell core as in rodents.
Islets make up 1 to 2 percent of pancreas volume yet receive 10 to 15 percent of its blood flow.
Development & Maturation
Stem-cell differentiation toward beta cells proceeds through the BMP4 pathway and kinase C signaling.
Zebrafish regenerate beta cells throughout life; krt4-expressing ductal cells serve as ductal progenitors.
Mouse beta cells regenerate after stress; human ones might not be as versatile.
Physiological Role
Beta cells use glucokinase to catalyze the first step of glycolysis, so metabolism tracks only physiological glucose and above.
Human beta cells mainly use GLUT1 and GLUT3 transporters; rodent ones primarily express GLUT2.
At rest, KATP channels hold the membrane near -70 mV; raised ATP closes them, depolarizing the cell, opening voltage-gated calcium channels and triggering insulin exocytosis.
An amplifying pathway boosts secretion without further calcium rise, via glucose metabolites and incretins.
Amylin complements insulin by slowing gastric emptying from the stomach.
Clinical Relevance
Type 1 diabetes is autoimmune insulitis — antigen-presenting cells, CD4+ T cells and CD8+ cytotoxic T cells — destroying 70 to 80 percent of beta cells.
In type 2 diabetes, insulin resistance makes beta cells raise function, size and number — until function halves and volume drops some 40 percent.
Impaired secretion produces the chronic hyperglycemia of type 2 diabetes, afflicting more than 450 million people worldwide.